Table 1.
Meta-analysis of laboratory findings between COVID-19 and Non-COVID-19 patients.
| Parameters | No. of cohort | Sample size (COVID-19/non-COVID-19) | SMD | 95% CI | I2 (%) | Statistical method | p |
|---|---|---|---|---|---|---|---|
| Leukocyte (×109/L) | 7 | 189/474 | −0.42 | −0.60 to −0.25 | 48 | FEM | <0.00001* |
| Lymphocyte (×109/L) | 7 | 189/474 | −0.37 | −0.81 to −0.07 | 78 | REM | 0.10 |
| Neutrophil (×109/L) | 6 | 170/468 | −0.23 | −0.41 to −0.06 | 38 | FEM | 0.01* |
| Thrombocyte (×109/L) | 5 | 168/427 | −0.54 | −0.91 to −0.16 | 70 | REM | 0.005* |
| D-dimer (μg/mL) | 2 | 63/107 | −0.27 | −0.59 to 0.06 | 0 | FEM | 0.11 |
| CRP (mg/L) | 6 | 168/416 | 0.29 | −0.33 to 0.90 | 87 | REM | 0.35 |
| PCT (ng/mL) | 3 | 136/338 | −0.44 | −1.20 to 0.32 | 91 | REM | 0.26 |
SMD, standard mean difference; CI, confidence interval, FEM, fixed-effect model; REM, random-effect model.
p < 0.05.